IRMD Iradimed Earnings and EPS analysis

EPS in 2026 (TTM): $1.89

Last Report Period Date: Sep 30, 2026

As of November 2026, according to Iradimed's latest financial report, the company's current EPS (TTM) is $1.89. Iradimed's EPS for 2025 came in at $1.77, marking an increase from $1.52 in 2024. Iradimed's earnings per share for the quarterly report ending on Sep 30, 2026 was $0.51.

The annual EPS in 2025 was $1.77, an increase of 16.4% from $1.52 in 2024. The quarterly EPS for the period ending Sep 30, 2026, was $0.51, marking a 15.9% increase from the same quarter last year. IRMD's TTM EPS stands at $1.89 as of September 2026. Iradimed's EPS for 2024 stood at $1.52, a 11.8% increase from 2023.

Iradimed has recorded an increase in EPS of 15.9% over the last 12 months (YoY, quarterly). For the last three years, IRMD recorded an average annual EPS growth rate of 20.2%. Iradimed had an average annual EPS growth rate of 74.3% over the last 5 years. Across the last decade, IRMD had an average annual EPS growth of 10%.